The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

A new approach pioneered by Aalto University scientists uses controlled warmth to trigger self-repair within retinal cells ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

Menlo Park resident Carmen Caricchio is on a quest to cure childhood inherited retinal diseases, a group of rare conditions that cause the degeneration of the retina and can lead to vision impairment ...

Commonly known as ‘Red Gold,’ this ancient remedy is widely known as the world’s most expensive spice and may also aid in ...